Suppr超能文献

第二代抗精神病药物在儿童和青少年中的应用。

Second-Generation Antipsychotic Drugs for Children and Adolescents.

机构信息

Department of Psychiatry, Tokai University School of Medicine.

出版信息

J Nippon Med Sch. 2021 Mar 11;88(1):10-16. doi: 10.1272/jnms.JNMS.2021_88-108. Epub 2020 Sep 30.

Abstract

The effectiveness and safety of antipsychotics have not been fully established in children and adolescents. Many antipsychotics approved for use in adults are prescribed off-label to children and adolescents. We investigated the effectiveness and tolerability of antipsychotics for children and adolescents with schizophrenia and bipolar disorder. A literature review of the empirical evidence regarding the use of antipsychotics, particularly second-generation antipsychotics, in children and adolescents showed that these drugs were safe and effective for this population. Antipsychotics were similarly effective for treatment of schizophrenia and bipolar disorder in children and adolescents. When prescribing antipsychotics to this population, clinicians should consider adverse events and the discontinuation rate in treated patients. However, the current evidence shows a lack of consensus regarding the use of antipsychotics in children and adolescents.

摘要

抗精神病药在儿童和青少年中的疗效和安全性尚未得到充分证实。许多已批准用于成人的抗精神病药被超适应证用于儿童和青少年。我们研究了抗精神病药治疗精神分裂症和双相情感障碍儿童和青少年的疗效和耐受性。一项关于抗精神病药(特别是第二代抗精神病药)在儿童和青少年中使用的实证证据的文献综述表明,这些药物对该人群是安全有效的。抗精神病药在儿童和青少年精神分裂症和双相情感障碍的治疗中同样有效。当为该人群开处方抗精神病药时,临床医生应考虑不良事件和治疗患者的停药率。然而,目前的证据表明,在儿童和青少年中使用抗精神病药缺乏共识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验